{"title":"颧骨种植体支撑假体的长期成功率和生物学并发症分析","authors":"K. Dash, Kondeti Naga Venkata Lakshmi Praveena, Samir Mansuri, Rozina Hussain Ali, Kunchala Sailasri, Shivani Karre, Anil Managutti","doi":"10.4103/jpbs.jpbs_308_24","DOIUrl":null,"url":null,"abstract":"ABSTRACT\n \n \n \n Patients with significant maxillary atrophy who are not candidates for standard implants now have an option thanks to zygomatic implants. Long-term statistics on difficulties and success are, however, scarce.\n \n \n \n A tertiary care center’s patient data were retrospectively analyzed. Included were patients who underwent zygomatic implant surgery between 2017 and 2022. This research gathered and examined data on follow-up, surgical techniques, complications, demographics, and implant features.\n \n \n \n There were 100 patients in all. 92% of the implants were successful, and 92 of them survived. Peri-implantitis (20%), soft tissue dehiscence (15%), sinusitis (10%), prosthesis fracture (8%), and infection (5%), were among the biological consequences. In summary, zygomatic implants have the potential to help individuals with severe maxillary atrophy recover, but close observation and effective management of any problems are necessary to maximize results. To enhance patient care and improve treatment regimens, further research is required.\n","PeriodicalId":16824,"journal":{"name":"Journal of Pharmacy and Bioallied Sciences","volume":" 4","pages":""},"PeriodicalIF":0.8000,"publicationDate":"2024-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Analysis of Long-Term Success and Biological Complications in Zygomatic Implant-Supported Prostheses\",\"authors\":\"K. Dash, Kondeti Naga Venkata Lakshmi Praveena, Samir Mansuri, Rozina Hussain Ali, Kunchala Sailasri, Shivani Karre, Anil Managutti\",\"doi\":\"10.4103/jpbs.jpbs_308_24\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"ABSTRACT\\n \\n \\n \\n Patients with significant maxillary atrophy who are not candidates for standard implants now have an option thanks to zygomatic implants. Long-term statistics on difficulties and success are, however, scarce.\\n \\n \\n \\n A tertiary care center’s patient data were retrospectively analyzed. Included were patients who underwent zygomatic implant surgery between 2017 and 2022. This research gathered and examined data on follow-up, surgical techniques, complications, demographics, and implant features.\\n \\n \\n \\n There were 100 patients in all. 92% of the implants were successful, and 92 of them survived. Peri-implantitis (20%), soft tissue dehiscence (15%), sinusitis (10%), prosthesis fracture (8%), and infection (5%), were among the biological consequences. In summary, zygomatic implants have the potential to help individuals with severe maxillary atrophy recover, but close observation and effective management of any problems are necessary to maximize results. To enhance patient care and improve treatment regimens, further research is required.\\n\",\"PeriodicalId\":16824,\"journal\":{\"name\":\"Journal of Pharmacy and Bioallied Sciences\",\"volume\":\" 4\",\"pages\":\"\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2024-06-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pharmacy and Bioallied Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/jpbs.jpbs_308_24\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmacy and Bioallied Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jpbs.jpbs_308_24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
Analysis of Long-Term Success and Biological Complications in Zygomatic Implant-Supported Prostheses
ABSTRACT
Patients with significant maxillary atrophy who are not candidates for standard implants now have an option thanks to zygomatic implants. Long-term statistics on difficulties and success are, however, scarce.
A tertiary care center’s patient data were retrospectively analyzed. Included were patients who underwent zygomatic implant surgery between 2017 and 2022. This research gathered and examined data on follow-up, surgical techniques, complications, demographics, and implant features.
There were 100 patients in all. 92% of the implants were successful, and 92 of them survived. Peri-implantitis (20%), soft tissue dehiscence (15%), sinusitis (10%), prosthesis fracture (8%), and infection (5%), were among the biological consequences. In summary, zygomatic implants have the potential to help individuals with severe maxillary atrophy recover, but close observation and effective management of any problems are necessary to maximize results. To enhance patient care and improve treatment regimens, further research is required.
期刊介绍:
Journal of Pharmacy And Bioallied Sciences is a Quarterly multidisciplinary open access biomedical journal. Journal of Pharmacy And Bioallied Sciences is an international medium of interaction between scientist, academicians and industrial personnel’s.JPBS is now offial publication of OPUBS.